Intrinsiqq
Nuvectis Pharma Inc. logo

Nuvectis Pharma Inc.

NVCT

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$667M
EPS-$1.88
P/E-10.31
P/FCF–
EV/EBITDA-10.09
FCF Yield–
Div. Yield–
Net Debt/FCF–
Nuvectis Pharma Inc. intrinsic value
52-Week Range
$5.81$28.53

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$50M

▼ -39.2% YoY

Op. Margin

–

ROIC

-97.83%

▼ -11.8pp YoY

Cash Flow & Balance Sheet

FCF

N/A

Op. Cash Flow (TTM)

-$40M

▼ -30.7% YoY

Net Debt

-$141M

Net Cash Position

Cash & Equiv.

$141M

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with NVCT

CompareIntrinsic value
DSGNDesign Therapeutics, Inc.
$9.02-3.22%10
SMMTSummit Therapeutics Inc.
$10.46-1.09%10
MDGLMadrigal Pharmaceuticals, Inc.
$379.10-4.45%10
ARDXArdelyx Inc.
$2.99-2.29%40
AQSTAquestive Therapeutics Inc.
$3.46-6.61%10
PFEPfizer Inc.
$27.40-0.51%30
BMRNBiomarin Pharmaceutical Inc.
$60.41-1.64%45
EBSEmergent BioSolutions Inc.
$5.05-1.94%37

Held by ETFs

NVCT is in 5 US ETFs. The largest of them, with NVCT's weight in each:

Nuvectis Pharma (NVCT) in two numbers

Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-10.31
Negative: a loss over the last twelve months.
Financials

Questions about Nuvectis Pharma

Does Nuvectis Pharma (NVCT) pay a dividend?

No. Nuvectis Pharma (NVCT) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 30 Oct 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in NVCT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing NVCT

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.